Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000012

Chief Operating Officer gave up 1,028 shares (to pay taxes)

  • Chief Operating Officer acquired 28,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dowden Nathan J Chief Operating Officer 2023-03-01 Grant or award +28,400 73,683 D: show line 1 in the form
Dowden Nathan J Chief Operating Officer 2023-03-02 Shares withheld for taxes −1,028 $11.60 $11,921 72,655 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dowden Nathan J Chief Operating Officer 2023-03-01 Grant or award · Stock Option (Right to Buy) +43,000 43,000 D: show line 3 in the form
Loading xslF345X03/wf-form4_167787916889742.xml…